Walgreens Boots Alliance Stock

$11.98

0.00%

Nasdaq, Tue, Sep 02 2025

ISIN

US9314271084

Symbol

WBA

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P 500

Sector

Consumer Staples Distribution & Retail

Industry

Consumer Staples Distribution & Retail

Overview Dividends Analysts Charts News Strategies

Walgreens Boots Alliance Stock price

$11.98

-25.19 67.77% 5Y

Nasdaq, Closing price Tue, Sep 02 2025

+0.00 0.00%

ISIN

US9314271084

Symbol

WBA

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P 500

Sector

Consumer Staples Distribution & Retail

Industry

Consumer Staples Distribution & Retail

Key metrics

Basic

Market capitalization

$10.4b

Enterprise Value

$17.9b

Net debt

$7.5b

Cash

$830.0m

Shares outstanding

865.2m

Valuation (TTM | estimate)

P/E

negative | 6.7

P/S

0.1 | 0.1

EV/Sales

0.1 | 0.1

EV/FCF

30.9

P/B

1.4

Dividends

DPS

$1.23

Yield 1Y | 5Y

10.3% | 4.5%

Growth 1Y | 5Y

-35.9% | -7.1%

Payout 1Y | 3Y

-12.3% | -59.1%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$154.6b | $156.2b

EBITDA

$5.8b | $3.8b

EBIT

$3.4b | $2.3b

Net Income

$-6.3b | $1.5b

Free Cash Flow

$579.0m

Growth (TTM | estimate)

Revenue

6.2% | 5.8%

EBITDA

31.3% | -24.5%

EBIT

69.9% | -10.8%

Net Income

-8.4% | 117.9%

Free Cash Flow

164.9%

Financial Health

Equity Ratio

12.9%

Return on Equity

-82.7%

ROCE

7.9%

ROIC

8.4%

Debt/Equity

1.2

EPS

$-7.3

FCF per Share

$0.7

Short interest

3.6%

Employees

253k

Rev per Employee

$580.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Walgreens Boots Alliance Stock Analysis

Unlock Scores for Free

??

19 Analysts have issued a Walgreens Boots Alliance forecast:

4x Buy

21%

15x Hold

79%

More details on Analyst Estimates Including Price Targets

19 Analysts have issued a Walgreens Boots Alliance forecast:

Buy

21%

Hold

79%

Analyst Estimates with Stock Price Targets

Financial data from Walgreens Boots Alliance

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

May '25		+/- %
Revenue	154,580 154,580	6% 6% 100%
- Direct Costs	128,108 128,108	8% 8% 83%
Gross Profit	26,472 26,472	1% 1% 17%
- Selling and Administrative Expenses	23,056 23,056	7% 7% 15%
- Research and Development Expense	- -	- -
EBITDA	5,849 5,849	31% 31% 4%
- Depreciation and Amortization	2,431 2,431	0% 0% 2%
EBIT (Operating Income) EBIT	3,418 3,418	70% 70% 2%
Net Profit	-6,298 -6,298	8% 8% -4%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Walgreens Boots Alliance Stock News

Neutral

Fast Company

●

6 days ago

Walgreens names Mike Motz as CEO after going private with Sycamore Partners

Walgreens on Thursday named retail veteran Mike Motz as its chief executive officer after the U.S. pharmacy chain was taken private by Sycamore Partners, marking a fresh chapter for the company that has been struggling to keep pace with rivals.

Neutral

PYMNTS

●

6 days ago

Sycamore Completes Acquisition of Walgreens Boots Alliance, Forms 5 Companies

Sycamore Partners said Thursday (Aug. 28) that it completed its acquisition of Walgreens Boots Alliance and that the businesses that made up WBA are now operating as standalone companies under private ownership. Those companies include Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD, Sycamore said in a Thursday press release.

Neutral

Reuters

●

6 days ago

Walgreens names Mike Motz as CEO, goes private under Sycamore Partners

Walgreens on Thursday named retail veteran Mike Motz as chief executive after the U.S. pharmacy chain was taken private by Sycamore Partners, marking a fresh chapter for the company that has been struggling to keep pace with rivals.

More Walgreens Boots Alliance News

Company Profile

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.

Head office	United States
CEO	Timothy Wentworth
Employees	252,500
Founded	1909
Website	www.walgreensbootsalliance.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now